Form 4: Amprius Technologies Executive Reports Stock Option Grant and Holdings Distribution
SEC Form 4 Filing
Jonathan Bornstein, President of Amprius Lab, reports stock option grants and a pro rata distribution of shares following Amprius, Inc.'s dissolution.
Summary
- Jonathan Bornstein, President of Amprius Lab, filed a Form 4 detailing changes in his beneficial ownership of Amprius Technologies, Inc. stock.
- The report includes the receipt of 133,536 shares from a pro rata distribution by Amprius, Inc. following its dissolution.
- Bornstein also received options to purchase 3,471 shares at $0.98 and 27,768 shares at $0.62, both fully vested.
- These options were assumed by Amprius Technologies in exchange for stock options previously held in Amprius Holdings.
- Bornstein directly owns 1,661,787 shares of Amprius Technologies common stock, which includes 489,064 restricted stock units.
Sentiment
Score: 6
Explanation: The document is a routine filing related to executive compensation. The sentiment is neutral as it simply reports transactions.
Positives
- The granting of stock options to a key executive like the President of Amprius Lab could be seen as an incentive to drive company performance.
- The assumption of options from Amprius Holdings suggests a continuation of previous equity incentive plans.
Industry Context
Executive stock ownership and option grants are common practices in the technology industry to align management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a standard component of compensation packages for executives in technology companies, often benchmarked against peer companies of similar size and stage.
- The vesting schedules and exercise prices are typically structured to incentivize long-term value creation.
Stakeholder Impact
- The stock option grants could potentially dilute existing shareholders if the options are exercised.
- The grants also incentivize the executive to improve company performance, which would benefit shareholders.
Key Dates
| Date | Description |
|---|---|
| 10/23/2024 | Date of earliest transaction (stock option grant). |
| 03/17/2025 | Expiration date for options to buy 3,471 shares. |
| 03/15/2027 | Expiration date for options to buy 27,768 shares. |
| 10/25/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.